GW Cancer Center

What GW Cancer Center does

GW Cancer Center, legally The George Washington University Cancer Center, is an academic medical center cancer institute established in 2021 as a unified component of George Washington University, integrating the GW School of Medicine and Health Sciences, GW Medical Faculty Associates, GW Hospital, and the Milken Institute School of Public Health. The center provides comprehensive cancer care across the full continuum including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and hormonal therapy, delivered through multidisciplinary specialist teams in Washington, DC. Its core product portfolio spans cancer treatment services, clinical trials (First-in-Human Phase I through Phase III), and preventive screening programs covering breast, lung, prostate, colorectal, cervical, head and neck, and skin cancers, supplemented by patient support services, survivorship care, genetic counseling, and community outreach.

The center's technical footprint includes first-in-region deployment of the UroNav fusion MRI-ultrasound biopsy platform for prostate cancer, first-in-world use of the Medrobotics Flex Robotic System for colorectal surgery, the da Vinci surgical robot, and an integrated diagnostic stack incorporating 4KScore, Prostate Health Index, SelectMDx, ConfirmMDx, Oncotype DX, and Decipher genomic testing. It treats common cancers such as breast, lung, prostate, and colorectal alongside rare and complex conditions, with patient acquisition driven by provider referrals, direct requests, community outreach, and clinical trial recruitment.

As a nonprofit university component, GW Cancer Center generates revenue through professional clinical services, screening programs, and clinical trial operations, with pricing varying by insurance coverage and treatment complexity. Free screening programs are offered for eligible individuals. The center pursues a stated goal of NCI designation within a decade and emphasizes cancer policy influence given its location in the nation's capital. The leadership team includes Rachel Brem as Professor and Vice Chair of Radiology and Breast Cancer Program Leader. No external funding rounds, M&A activity, or ownership changes have been disclosed.

Name

GW Cancer Center

Legal name

The George Washington University Cancer Center

Website

https://cancercenter.gwu.edu

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

101–250 employees

Short description

GW Cancer Center is a Washington, DC-based academic medical center that diagnoses and treats cancer patients across multiple cancer types, delivering multidisciplinary care, clinical trials, screening, and survivorship services as a component of George Washington University.

Ownership category

akta.pro rank

Product category

Cancer Care and Oncology Services

NAICS

General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Cancer treatment services
• Clinical oncology programs
• Cancer screening diagnostics
• Clinical trials oncology
• Cancer survivorship support

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Care Services: Comprehensive cancer treatment services including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy delivered through multidisciplinary care teams.
2. Clinical Trials: Access to groundbreaking clinical trials including First-in-Human Phase I, Phase II, and Phase III trials, providing investigational therapies to eligible patients.
3. Cancer Screening Services: Preventive screening services for breast, cervical, colorectal, lung, prostate, head & neck, and skin cancers, including imaging and diagnostic procedures.
4. Support Services: Support groups, survivorship programs, genetic counseling, nutrition services, social services, and patient navigation.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

The GW Cancer Center is an academic medical center that diagnoses and treats cancer patients through multidisciplinary coordinated care. It provides comprehensive cancer treatment (surgery, chemotherapy, radiation, immunotherapy, targeted therapy), preventive screening, clinical trials, and survivorship/support services for patients and families in the greater Washington DC region.

Product overview

GW Cancer Center is a comprehensive cancer care center providing a unified set of cancer treatment and support services. The core offerings include cancer treatment services (surgery, chemotherapy, radiation, immunotherapy, targeted therapy), clinical trials, and cancer screening programs. These are supported by patient support services including support groups, survivorship care, genetic testing and counseling, community outreach, and patient/caregiver support. The center also provides specialized services such as breast imaging, advanced diagnostic testing, and minimally invasive surgery using robotic systems. Educational resources including podcasts complement the clinical services.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Treatment Services Comprehensive cancer care including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and hormonal therapy delivered by multidisciplinary specialist teams for patients with common and rare cancers.
• Clinical Trials Access to innovative therapies and investigational treatments through First-in-Human Phase I, Phase II, Phase III, supportive care, and prevention trials for eligible cancer patients.
• Cancer Screening Programs Preventive screening for breast, cervical, colorectal, lung, prostate, head and neck, and skin cancers, including 2D/3D mammography, ABUS, molecular breast imaging, low-dose CT, PSA tests, and digital rectal exams.
• Patient Support Groups Virtual support groups for patients and families including GI Support Group, GYN Support Group, Leukemia and Lymphoma Support Group, Mindfulness and Meditation Group, Multiple Myeloma Support Group, and Prostate Cancer Support Group.
• Survivorship Services Comprehensive survivorship care for patients who have completed cancer treatment, addressing long-term health needs and quality of life.
• Community Outreach and Engagement

Quantifiable outcome

• Stage 0 minimally invasive adenocarcinoma caught through lung cancer screening and treated successfully
• +1 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature9 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Smith Center for Healing and the ArtscoreStrategic or Co-development PartnerPartnership providing integrative healing support services for cancer patients. The Smith Center offers caregiver support and was involved in providing support services to GW Cancer Center patients during their treatment journey.
• Imerman AngelsminorStrategic or Co-development PartnerCancer support non-profit organization providing peer-to-peer support. GW Cancer Center patient Kia Toye completed training to become a mentor with this organization.
• Tigerlily FoundationminorStrategic or Co-development PartnerBreast cancer foundation focused on supporting young women. GW Cancer Center patient Kia Toye serves as an Angel Advocate advocating for women in early diagnosis.
• Medrobotics CorporationcoreTechnology or IntegrationGW Hospital was the first hospital in the world to perform colorectal surgery with the Medrobotics Flex Robotic System. This technology enables surgeons to access hard-to-reach anatomy through the body's natural opening without abdominal incisions.
• Intuitive Surgical (da Vinci)coreTechnology or IntegrationDa Vinci surgical robot system used for minimally invasive robotic surgery including prostatectomy, offering benefits of decreased hospital stay, reduced infection risk, decreased pain and scarring, and faster recovery.
• UroNav (Invivo)coreTechnology or IntegrationUroNav fusion MRI-ultrasound biopsy platform. GW Cancer Center was first in the region to use this platform which fuses pre-biopsy MRI images with ultrasound images to accurately guide biopsy needles in real time.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Inova Schar Cancer Institute: Inova Schar is a major regional academic-affiliated cancer program in Northern Virginia, directly competing with GW Cancer Center for patients across the DC metropolitan area, particularly in Fairfax and the Virginia suburbs. It offers multidisciplinary oncology, clinical trials, and advanced therapies comparable to GW's offering.
• Georgetown Lombardi Comprehensive Cancer Center: Georgetown Lombardi is the other NCI-designated comprehensive cancer center in Washington, DC, affiliated with MedStar Georgetown University Hospital. It competes with GW Cancer Center for the same DC-metro patient population, physician referrals, clinical trial enrollment, and talent pool, and serves as the most direct head-to-head comparator.
• Johns Hopkins Sidney Kimmel Cancer Center: Sidney Kimmel is an NCI-designated comprehensive cancer center in Baltimore that draws patients from across the mid-Atlantic including the DC metro. It competes for high-acuity cases, complex surgeries, and clinical trial referrals, and operates Johns Hopkins-affiliated community sites that overlap GW's catchment area.
• University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center: UM Greenebaum is an NCI-designated comprehensive cancer center in Baltimore offering multidisciplinary oncology care, clinical trials, and translational research. It competes with GW for mid-Atlantic patients, research talent, and industry-sponsored trial placement.

Broad incumbents

• Duke Cancer Institute: Duke Cancer Institute is an NCI-designated cancer center at Duke University offering comprehensive oncology care and clinical trials. As a peer academic cancer program at a private research university of similar scale to GW, it provides a structural benchmark for operating model, research portfolio, and NCI-designation pathway.
• MedStar Georgetown University Hospital: MedStar Georgetown is a large academic medical center whose Lombardi Cancer Center is GW's closest DC competitor. It is a broader incumbent offering full hospital services beyond oncology, with which GW Cancer Center competes for tertiary referrals in the DC market.
• Memorial Sloan Kettering Cancer Center: MSK is a national NCI-designated comprehensive cancer center that, while not a direct DC competitor, attracts cross-region and international patients seeking top-tier cancer care. It serves as the benchmark for academic cancer center operations and the aspirational peer for GW's NCI-designation trajectory.
• National Cancer Institute (NCI) Clinical Center: NCI's intramural clinical center in Bethesda, MD, treats patients on investigational protocols and is the federal benchmark for cancer research. Located within GW's broader catchment, it draws patients seeking first-in-human trials and serves as both a competitor and a partner reference point for GW's NCI-designation aspirations.

Regional players

• Virginia Cancer Specialists: Virginia Cancer Specialists is a large community oncology practice in Northern Virginia providing medical oncology, hematology, radiation, and clinical trial services. It competes with GW Cancer Center for community-based cancer patients in the DC metro suburbs, particularly for non-academic referrals.
• Sibley Memorial Hospital (Johns Hopkins): Sibley is a Johns Hopkins-affiliated community hospital in Washington, DC offering oncology services that overlap with GW's outpatient catchment. While not an NCI center itself, it channels complex oncology referrals into the Hopkins Kimmel Cancer Center and competes with GW for DC-resident patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GWCancer
• Facebookfacebook.com/gwcancercenter
• LinkedInlinkedin.com/company/george-washington-university

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GW Cancer Center